Novartis has secured European Commission approval for Itvisma for the treatment of children aged two years and older, as well ...

Applications have opened for the ninth cohort of KQ Labs, the national accelerator for data‑driven health start‑ups delivered ...

AlzeCure Pharma has signed an out‑licensing and collaboration agreement with Danish biotech QuantumCell ApS, granting global ...

R1 Therapeutics has formed a scientific advisory board comprising seven internationally recognised nephrology experts as the ...

Lundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27–30 June in ...

Agomab Therapeutics has announced the design of its phase 2b NOV‑ERA study of ontunisertib in fibrostenosing Crohn’s disease, ...

Racura Oncology has treated the first patient in its phase 1 HARNESS‑1 clinical trial of RC220 for EGFR‑mutant non‑small cell ...

The European Commission has approved Sanofi’s Cenrifki (tolebrutinib) for adults with secondary progressive multiple ...

Company secures first commercial product with data for active and chronic TED Viridian Therapeutics has received US FDA approval for Lumvoa (veligrotug-vvze) for thyroid eye disease, marking the first ...

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative ...

Boehringer Ingelheim has reported positive topline results from the phase III SYNCHRONIZE‑1 trial, showing that its investigational dual glucagon/GLP‑1 agonist survodutide achieved sustained and ...

Compressed air is among the largest energy expenses in pharmaceutical manufacturing and must remain entirely contamination-free.